Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07865715Not yet recruiting
Randomised, double-blind trial in chronic rhinosinusitis (CRS) (2 arms), sponsored by Taichung Veterans General Hospital. Primary endpoints: Sino-Nasal Outcome Test at 3 months and Self-reported adverse events at 2 months. Planned start Oct 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07865715.